Inspection Record

Natco Pharma Limited — Health Canada Inspection Findings

Health CanadaInspected 2023-06-19 5 findingsContamination controlStability and storageDeviation, CAPA, and investigationComputer system validationOther quality system

View the regulator's official source The source document is always the basis for judgement.

Findings

1Contamination control

The sanitation programs were not adequately designed to identify and/or reduce the risks of contamination.

2Stability and storage

The procedures in place were inadequate for the storage, transportation, records, and/or testing of purchased media.

3Deviation, CAPA, and investigation

The evaluation was inadequate for cases where there was a deviation from the norm and/or where products were on the borderline of the acceptable range.

4Computer system validation

The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate. The creation, maintenance, processing, and/or review of laboratory data was inadequate.

5Other quality system

Critical production processes were not validated.

About this record

Extracted automatically from the document of the Health Canada inspection on 2023-06-19. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Natco Pharma Limited company profile — full history Health Canada documents, 2023 Go to Findings search